ArriVent BioPharma, Inc.
AVBP NASDAQ







Weekly Report
ArriVent BioPharma, Inc. closed at 17.6500 (-10.50% WoW) . Data window ends Mon, 15 Sep 2025.
How to read this โ Price slope is upward, indicating persistent buying over the window. Elevated weekly volatility increases whipsaw risk. Volume and price are moving in the same direction โ a constructive confirmation. Price is extended below its baseline; rebounds can be sharp if demand improves. Price sits below key averages, keeping pressure on the tape.
Up-slope supports buying interest; pullbacks may be contained if activity stays firm.
Gauge maps the trend signal to a 0โ100 scale.
How to read this โ Range-bound conditions; conviction is limited until a break or acceleration emerges.
Wait for a directional break or improving acceleration.
Conclusion
Negative setup. โ โโโโ confidence. Price window: -5. Trend: Range / Neutral; gauge 16. In combination, liquidity confirms the move.
- Liquidity confirms the price trend
- Momentum is weak/falling
- Price is not above key averages
- High return volatility raises whipsaw risk
- Negative multi-week performance
Why: Price window -5.41% over 8w. Close is -12.58% below the prior-window high. Return volatility 6.96%. Volume trend rising. Liquidity convergence with price. Trend state range / neutral. Low-regime (โค0.25) upticks 3/7 (43.0%) โข Distributing. Momentum bearish and falling.
Tip: Most metrics include a hover tooltip where they appear in the report.